Biomensio is developing the next generation multianalyte biosensing, smart, quick, and mobile.
Our technology platform consists of a fully digital multianalyte sensor, fluid cartridges and a handheld reader, with a customer specific API or a cloud-based analytics service. Benefits of our technology include quick test results at point-of-need, high level of multiplexing, accuracy and ease of digital connectivity.
The initial application areas include the detection of SARS-CoV-2 and Drugs of Abuse in saliva, as well as food and milk safety.
Our vision is to enable truly mobile biosensing, requiring just one drop of sample, blood or saliva to give accurate, rapid and multiplexed results at the point-of-need in a few minutes time.